| Financial Year |
March 31 2023 |
| Monetary Funds |
968,108,364.48 |
| Held-for-trading Financial Assets |
27,471,195.29 |
| Notes Receivable |
279,144,127.30 |
| Accounts Receivable |
531,809,580.30 |
| Advances to Suppliers |
7,001,799.53 |
| Other Receivables |
20,426,414.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
484,584,058.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,936,203.50 |
| Total Current Assets |
2,325,481,743.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
45,473,835.75 |
| Long-term Equity Investment |
92,843,181.54 |
| Investment Properties |
102,675,951.04 |
| Fixed Assetes |
146,563,333.74 |
| Under-construction Projects |
351,767.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,010,398.03 |
| R&D expenses |
-- |
| Goodwill |
413,526,033.33 |
| Long-Term Deferred and Prepaid Expenses |
13,696,669.71 |
| Deferred Income Tax Assets |
12,380,234.42 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
886,554,977.89 |
| Total Assets |
3,212,036,720.98 |
| Short-Term Loans |
96,539,066.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,357,507.00 |
| Accounts Payable |
268,035,898.58 |
| Accounts Received In Advance |
2,361,720.85 |
| Employee Compensation Payable |
18,111,403.24 |
| Taxes Payable |
26,412,222.44 |
| Interest Payable |
6,858.50 |
| Dividend Payable |
-- |
| Other payables |
125,313,089.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,383,332.91 |
| Other Current Liabilities |
211,366,500.52 |
| Sub-Total of Current Liabilities |
899,111,230.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,842,123.74 |
| Other Non-Current Liabilities |
54,000,000.00 |
| Sub-Total of Non-Current Liabilities |
73,316,724.35 |
| Total Liabilities |
972,427,954.69 |
| Paid-In Capital(Or Share Stock) |
924,333,311.00 |
| Capital Surplus |
203,419,997.67 |
| Surplus Reserve |
318,402,685.19 |
| LESS:Treasury Stock |
9,281,880.00 |
| Undistributed Profits |
672,690,421.33 |
| Minority Stockholder's Interest |
128,640,857.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,110,967,908.70 |
| Owner's Equity（Stockholder's Equity） |
2,239,608,766.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,212,036,720.98 |
